MedTrace Logo

Sentinel Node Mapping in Women With Endometrial and Cervical Cancer

NCT02820506 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-02-08

No results posted yet for this study

Summary

The aim of the study is to evaluate the feasibility of applying the SLN mapping technique in combination with FDG-PET/CT imaging in women with high-risk histology endometrial cancer and in patients with cervical cancer tumour size 2-4 cm.

Conditions

  • Uterine Cervical Neoplasms
  • Uterine Neoplasms

Interventions

PROCEDURE

SLN mapping and removal of PET-positive lymph nodes

Sentinel node mapping will be performed, followed by systematic removal og PET/CT positive lymph nodes

Sponsors & Collaborators

  • Odense University Hospital

    collaborator OTHER

  • Danish Cancer Society

    collaborator OTHER

  • University of Southern Denmark

    lead OTHER

Principal Investigators

  • Pernille T Jensen, Professor · Aarhus University Hospital and Aarhus University, Denmark

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-27
Primary Completion
2023-01-31
Completion
2026-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02820506 on ClinicalTrials.gov